Characterization of the c.793-1G > A splicing variant in CHEK2 gene as pathogenic: a case report | BMC Medical Genetics | Full Text

Characterization of the c.793-1G > A splicing variant in CHEK2 gene as pathogenic: a case report | BMC Medical Genetics | Full Text

BMC Medical Genetics

Characterization of the c.793-1G > A splicing variant in CHEK2 gene as pathogenic: a case report

• Konstantinos Agiannitopoulos, 
• Eirini Papadopoulou, 
• Georgios N. Tsaousis, 
• Georgia Pepe, 
• Stavroula Kampouri, 
• Mehmet Ali Kocdor & 
• George Nasioulas 

BMC Medical Geneticsvolume 20, Article number: 131 (2019) | Download Citation

Abstract

Background

CHEK2 is involved in the DNA damage repair response Fanconi anemia (FA)-BRCA pathway. An increased risk for breast and other cancers has been documented in individuals who carry a single pathogenic CHEK2 variant. As for other genes involved in cancer predisposition, different types of pathogenic variants have been observed, including single nucleotide variations, short insertions/deletions, large genomic rearrangements and splicing variants. Splicing variants occurring in the splicing acceptor or donor site result in alternative mature mRNA produced and can cause intron retention, exon skipping, or creation of alternative 3′ and 5′ splice site. Thus, the pathogenicity of this type of alterations should always be explored experimentally and their effect in the mRNA and consequently the protein produced, should be defined. The aim of this study was the delineation of the effect of a splicing variant in the CHEK2 gene.

Case presentation

A healthy 28-year-old woman with a family history of breast and ovarian cancer was referred for genetic testing. The variant c.793-1G > A (rs730881687) was identified by Next Generation Sequencing (NGS) using a solution-based capture method, targeting 33 cancer predisposition genes (SeqCap EZ Probe library, Roche NimbleGen). Experimental analysis in patient-derived leukocytes using RT-PCR of mRNA followed by cDNA sequencing revealed the deletion of one base from the alternative transcript created (r.793del). This resulted in a frameshift leading to premature termination codon within exon 7 (p.(Asp265Thrfs*10)).

Conclusions

This finding suggests that the CHEK2 splicing variant c.793-1G > A is a deleterious variant. Our case shows that RNA analysis is a valuable tool for uncharacterized splice site variants in individuals referred for testing and facilitates their personalized management.